Technology | September 06, 2007

Contrast Delivery System Enhances Cost Efficiencies


Combining all features of the ACIST CMS and Voyager systems onto one platform, the ACIST CVi Contrast Delivery System for cardiovascular angiographic procedures enhances the ease
of contrast and saline injection for physicians, nurses and technicians.
The ACIST CVi Contrast Delivery System serves as one injection system for all cardiac and vascular angiography procedures. Its fourth-generation technology re-
portedly provides ease of use for staff, while obtaining images with less contrast used.
According to the manufacturer, the ACIST CVi delivers up to 28 percent less contrast dosage to the patient than manual delivery methods of hand-held manifolds and fixed-rate power injectors, resulting in up to 40 percent savings on reduction of contrast use.
Synchronization capabilities are part of this integrated system, further enhancing the flexible platform. The lower-profile, table-mountable injector and extendable control panel can be placed where it is needed most and with less interference.


Related Content

News | Contrast Media

August 17, 2023 — University of Missouri School of Medicine neurologist Adnan Qureshi, MD recently led a study that ...

Home August 17, 2023
Home
News | Contrast Media

July 3, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

Home July 03, 2023
Home
News | Contrast Media

May 11, 2021 — The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (ASE ...

Home May 11, 2021
Home
Technology | Contrast Media

July 15, 2019 — The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic ...

Home July 15, 2019
Home
Videos | Contrast Media

Sharon Mulvagh, M.D., FASE, FACC, FRCPC, professor of medicine, division of cardiology, Dalhousie University, Halifax ...

Home June 28, 2019
Home
Feature | Contrast Media | Dave Fornell, Editor

Iodine-based contrast agents used in computed tomography (CT) and catheter-based angiography have been implicated as a ...

Home May 31, 2019
Home
News | Contrast Media

May 9, 2019 — Osprey Medical announced the launch of DyeMINISH, a global patient registry to evaluate the ongoing safety ...

Home May 09, 2019
Home
News | Contrast Media

November 30, 2018 — VigiLanz and Cincinnati Children’s Hospital Medical Center recently announced a collaboration that ...

Home November 30, 2018
Home
News | Contrast Media

In February 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Maryland, to explore ...

Home September 12, 2018
Home
News | Contrast Media

January 19, 2018 — Ligand Pharmaceuticals Inc. announced initiation of a program to develop contrast agents with reduced ...

Home January 19, 2018
Home
Subscribe Now